All In MedTech

Device Trial Radar · NCT06578741

GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis Post-Approval Study

Last checked: Nov 19, 2026Latest source record: Jul 7, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruiting

Status

Active, not recruiting

Enrollment

310

Actual

Start

Nov 25, 2024

Primary completion

Jun 25, 2027

Study completion Jun 1, 2036

Sponsor

Lead sponsor
W.L.Gore & AssociatesNot on our public-company list
Sponsor type
Industry
First posted
Aug 29, 2024

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study aims to confirm that the benefit-risk assessment of the GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis (TAMBE Device) remains positive in real-world use and to ensure the adequacy of the TAMBE Device training program.

Conditions

  • Abdominal Aortic Aneurysm
  • Pararenal Aortic Aneurysm
  • Thoracoabdominal Aortic Aneurysm

Interventions

  • GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis (TAMBE Device)Device

    Treatment with the GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis (TAMBE Device) in patients with Pararenal Abdominal Aortic Aneurysms and Thoracoabdominal Aortic Aneurysms

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Co-Primary Endpoint #1: Technical SuccessTime frame: Time of index procedure
  2. Co-Primary Endpoint #2: Clinical SuccessTime frame: Index procedure through 12 months

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Stanford Hospital

    Stanford, California

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.